Berry Lance A, EVP, COO, CFO, and Treasurer of Artivion Inc. ($AORT), sold shares on the open market four times in the last year, totaling nearly $783 thousand. His most recent sale occurred on March 3, 2026. These sales rank him 5,462nd among over 11,600 insiders by value sold, below the average of $8.6 million across about 6.4 transactions per insider. He made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | ARTIVION, INC. | $AORT | Berry Lance A | EVP, COO, CFO & Treasurer | A | Common Stock | 40874 | $0.00 | 217,143.0000 | 49,330,000 | 23.19% | 0.08% |
| March 3, 2026 | ARTIVION, INC. | $AORT | Berry Lance A | EVP, COO, CFO & Treasurer | S | Common Stock | 6316 | $37.78 | 210,827.0000 | 49,330,000 | 2.91% | 0.01% |
| March 2, 2026 | ARTIVION, INC. | $AORT | Berry Lance A | EVP, COO, CFO & Treasurer | S | Common Stock | 5178 | $38.02 | 176,269.0000 | 49,330,000 | 2.85% | 0.01% |
| Feb. 24, 2026 | ARTIVION, INC. | $AORT | Berry Lance A | EVP, COO, CFO & Treasurer | A | Common Stock | 37482 | $0.00 | 181,447.0000 | 49,330,000 | 26.04% | 0.08% |
| Feb. 24, 2026 | ARTIVION, INC. | $AORT | Berry Lance A | EVP, COO, CFO & Treasurer | S | Common Stock | 4485 | $35.69 | 143,965.0000 | 49,330,000 | 3.02% | 0.01% |
| Feb. 23, 2026 | ARTIVION, INC. | $AORT | Berry Lance A | EVP, COO, CFO & Treasurer | S | Common Stock | 4981 | $37.59 | 148,450.0000 | 49,330,000 | 3.25% | 0.01% |
| May 20, 2025 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Berry Lance A | Not found | A | Common Stock | 23917 | $0.00 | 44,593.0000 | 62,618,725 | 115.68% | 0.04% |
| March 6, 2025 | ARTIVION, INC. | $AORT | Berry Lance A | Executive VP, CFO | A | Common Stock | 48100 | $0.00 | 158,340.0000 | 43,432,000 | 43.63% | 0.11% |
| March 6, 2025 | ARTIVION, INC. | $AORT | Berry Lance A | Executive VP, CFO | S | Common Stock | 4909 | $24.80 | 153,431.0000 | 43,432,000 | 3.10% | 0.01% |
| Feb. 28, 2025 | ARTIVION, INC. | $AORT | Berry Lance A | Executive VP, CFO | A | Common Stock | 34435 | $0.00 | 110,240.0000 | 43,432,000 | 45.43% | 0.08% |
| Feb. 24, 2025 | ARTIVION, INC. | $AORT | Berry Lance A | Executive VP, CFO | S | Common Stock | 3259 | $27.31 | 75,805.0000 | 43,432,000 | 4.12% | 0.01% |
| May 21, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Berry Lance A | Not found | A | Common Stock | 15091 | $0.00 | 20,676.0000 | 0 | 270.21% | 0.00% |
| May 21, 2024 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Berry Lance A | Not found | A | Stock Option (Right to Buy) | 33260 | $0.00 | 33,260.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2024 | ARTIVION, INC. | $AORT | Berry Lance A | Executive VP, CFO | A | Common Stock | 37000 | $0.00 | 79,064.0000 | 42,569,000 | 87.96% | 0.09% |
| May 23, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Berry Lance A | Director | A | Stock Option (Right to Buy) | 6305 | $0.00 | 6,305.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2023 | TREACE MEDICAL CONCEPTS, INC. | $TMCI | Berry Lance A | Director | A | Common Stock | 2753 | $0.00 | 5,585.0000 | 0 | 97.21% | 0.00% |